WBC and neutrophil results in minutes from a fingerstick sample
Athelas Home is an FDA-cleared, CLIA-waived hematology analyzer that delivers quantitative white blood cell count and neutrophil percentage at the point of care and at home, so care teams can act without waiting on central labs.
- Same-visit results to support faster clinical decisions
- Reduce missed monitoring and treatment delays tied to lab logistics
- One platform that follows the patient across care settings
AI-Powered
40,000+
patients supported
1,000,000+
tests performed
When results are delayed, care is delayed
Routine WBC and neutrophil monitoring often depends on venous draws, scheduling, transport, and lab turnaround. That friction creates missed tests, delayed decisions, and avoidable interruptions in care.
Move monitoring into the visit or the home workflow
Act on results while the patient is still in front of you
Expand access without expanding complexity
This technology has enabled clozapine for patients who had no other options. We can test, decide, and treat in one visit. No outside lab orders or coordinating extra transportation.
The Athelas Home finger stick device is a key element of our clozapine-centered practice. The ANC testing process is quick, fast, accurate and easier on our patients. Athelas Home relieves significant patient burden and lets us make treatment decisions real-time right in the office. No extra lab orders - just results.
Being able to run an ANC at the point of care and act on it immediately completely changes how we manage high-risk patients. With Athelas Home, we’ve eliminated extra lab visits, reduced delays in treatment, and simplified workflows.
Athelas Home allows us to get ANC results quickly and make treatment decisions in one visit. The technology has reduced lab coordination, shortened time to therapy, and made high-risk monitoring easier for staff and more comfortable for patients.
The use of finger prick blood testing instead of venipuncture is more acceptable for many patients and avoids the obstacle of traveling to a laboratory approach removes obstacles and offers advantages to patients who can benefit from this important medication.
Actionable hematology results where care happens
WBC
Quantitative white blood cell count
Faster decisions with fewer dependencies on high-complexity lab workflows
Neutrophil Percent
Quantitative neutrophil percentage
Less burden for patients who require frequent monitoring
ANC
Calculated to support neutrophil monitoring workflows
Consistent, repeatable workflow across settings and care teams
Built for high-frequency monitoring
Oncology and infusion care
Support monitoring with near-patient testing and faster decisions during visits.
Immunosuppressive therapy
Enable routine monitoring without adding repeated lab trips that drive missed tests.
Behavioral health and clozapine monitoring
Reduce friction in required monitoring workflows and support continuity of treatment.
Community and mobile care
Bring testing to outreach settings and programs that need results on site.
At-home monitoring
Enable testing from home to reduce missed labs and keep patients on therapy between visits.
Simple workflow.
Fast results.
Collect a fingerstick capillary sample
Run the test on Athelas Home
Review results in minutes and take next steps
Designed for routine monitoring at scale
Supports standardized operations across clinics and distributed care models
Built to fit into existing patient visit flows
See the full workflow live and assess fit in one call
If your teams manage frequent WBC or ANC monitoring, the fastest way to evaluate impact is to see the workflow end to end.
Time to result and on-site workflow walkthrough
Operational requirements, training, and rollout plan
Patient populations and settings fit assessment
Data flow, reporting, and program operations overview
.avif)
Get a demo
See how Athelas Home can reduce monitoring friction and accelerate decisions across your care settings.
Frequently Asked Questions
Quantitative WBC and neutrophil percentage results, with ANC calculated to support monitoring workflows.
Point-of-care settings and home workflows, aligned to your program requirements and patient eligibility.
Care teams managing patients who require routine WBC and neutrophil monitoring, including oncology, immunosuppression, and clozapine programs.
A rollout plan that covers training, supplies, operations, and program setup for your sites and care model.
Stop waiting on lab logistics
Bring routine WBC and ANC monitoring into the visit or home workflow and move faster with less friction.
Get a demo
Athelas Home is a prescription device. Results should be interpreted by qualified healthcare professionals and used in the context of clinical judgment and program requirements.